Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
The Journal of Infection
|
February 20, 2025
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
The Lancet Regional Health. Western Pacific
|
July 30, 2021
The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji
Adam W J Jenney, Rita Reyburn, Felisita T Ratu, et al.
The Journal of Infectious Diseases
|
May 11, 2021
Nasopharyngeal Pneumococcal Colonization Density Is Associated With Severe Pneumonia in Young Children in the Lao People's Democratic Republic
Olivia J J Carr, Keoudomphone Vilivong, Laddaphone Bounvilay, et al.
The Lancet. Global Health
|
November 14, 2018
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
Eileen M Dunne, Catherine Satzke, Felisita T Ratu, et al.
The Journal of Infection
|
March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Frontiers in Immunology
|
May 8, 2026
Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults
Nadia Mazarakis, Zheng Quan Toh, Tsetsegsaikhan Batmunkh, et al.
The Lancet Regional Health. Western Pacific
|
February 16, 2026
<i>Streptococcus pneumoniae</i> nasopharyngeal carriage in Vietnamese children during the first five years of life: a post hoc analysis
Fernanda Marincek, Beth Temple, Sam Manna, et al.
Nature Communications
|
September 29, 2025
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial
John D Hart, Eddy Fadlyana, Nadia Mazarakis, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
The Journal of Infection
|
February 20, 2025
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
The Lancet Regional Health. Western Pacific
|
July 30, 2021
The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji
Adam W J Jenney, Rita Reyburn, Felisita T Ratu, et al.
The Journal of Infectious Diseases
|
May 11, 2021
Nasopharyngeal Pneumococcal Colonization Density Is Associated With Severe Pneumonia in Young Children in the Lao People's Democratic Republic
Olivia J J Carr, Keoudomphone Vilivong, Laddaphone Bounvilay, et al.
The Lancet. Global Health
|
November 14, 2018
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
Eileen M Dunne, Catherine Satzke, Felisita T Ratu, et al.
The Journal of Infection
|
March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Frontiers in Immunology
|
May 8, 2026
Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults
Nadia Mazarakis, Zheng Quan Toh, Tsetsegsaikhan Batmunkh, et al.
The Lancet Regional Health. Western Pacific
|
February 16, 2026
<i>Streptococcus pneumoniae</i> nasopharyngeal carriage in Vietnamese children during the first five years of life: a post hoc analysis
Fernanda Marincek, Beth Temple, Sam Manna, et al.
Nature Communications
|
September 29, 2025
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial
John D Hart, Eddy Fadlyana, Nadia Mazarakis, et al.
Page
of 5